Search Results - "Hasselbalch, Benedikte"

A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution by Abedi, Armita Armina, Grunnet, Kirsten, Christensen, Ib Jarle, Michaelsen, Signe Regner, Muhic, Aida, Møller, Søren, Hasselbalch, Benedikte, Poulsen, Hans Skovgaard, Urup, Thomas

“…Glioblastoma patients administered standard therapies, comprising maximal surgical resection, radiation therapy with concomitant and adjuvant temozolomide,…”
Get full text

RTID-04. GLIOTARGET: A DANISH NATIONWIDE PHASE I/II PLATFORM TRIAL FOCUSING ON INDIVIDUALIZED TARGETED TREATMENT FOR NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS BASED ON GENOMIC PROFILING by Fougner, Vincent, Hasselbalch, Benedikte, Urup, Thomas, Lassen, Ulrik, Poulsen, Hans

Get full text

BIOM-39. GENETIC VARIANTS ASSOCIATED WITH DISTANT RECURRENCE IN GLIOBLASTOMA PATIENTS TREATED WITH STANDARD THERAPY by Fougner, Vincent, Chiranth, Shivani, Yde, Christina, Nørøxe, Dorte, Christensen, Ib, Hasselbalch, Benedikte, Lassen, Ulrik, Poulsen, Hans, Urup, Thomas

“…Infiltrative growth is a hallmark of glioblastoma and is a major factor in therapeutic failure. Genetic variants predictive of distant recurrence may serve as…”
Get full text

BIOM-24. PREDICTION OF DISTANT RECURRENCE IN GLIOBLASTOMA PATIENTS TREATED WITH STANDARD THERAPY by Chiranth, Shivani, Trip, Anouk, Christensen, Ib, Grunnet, Kirsten, Møller, Søren, Hasselbalch, Benedikte, Muhic, Aida, Lassen, Ulrik, Poulsen, Hans, Urup, Thomas

Get full text

Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme by Lassen, Ulrik, Sorensen, Morten, Gaziel, Tine Bernhardtsen, Hasselbalch, Benedikte, Poulsen, Hans Skovgaard

“…Bevacizumab combined with chemotherapy has recently shown promising efficacy in recurrent high-grade glioma. Phosphatase and tensin homolog (PTEN) mutation in…”
Get full text

Degradation fragments of Tau and type IV collagen as serum biomarkers in patients with recurrent glioblastoma treated with nivolumab and bevacizumab by Jensen, Christina, Maarup, Simone, Poulsen, Hans Skovgaard, Hasselbalch, Benedikte, Karsdal, Morten, Svane, Inge Marie, Lassen, Ulrik, Willumsen, Nicholas

“…There is an unmet need for new treatment options and biomarkers for patients with glioblastoma (GBM). Here we investigated three non-invasive biomarkers: type…”
Get full text

Indirect assessment of tumor-infiltrating lymphocyte activity in serum for predicting outcome in patients with glioblastoma treated with immunotherapy in the recurrent setting by Jensen, Christina, Maarup, Simone Bendix, Poulsen, Hans Skovgaard, Hasselbalch, Benedikte, Karsdal, Morten A., Svane, Inge Marie, Lassen, Ulrik Niels, Willumsen, Nicholas

“…2059 Background: Glioblastoma (GBM) is an aggressive brain tumor and despite efforts in developing new effective therapies, patient survival remains low. There…”
Get full text

CTNI-32. IMPLEMENTING GENOMIC PROFILING AS STANDARD-OF-CARE FOR GLIOBLASTOMA PATIENTS by Fougner, Vincent, Urup, Thomas, Hasselbalch, Benedikte, Poulsen, Hans, Rohrberg, Kristoffer, Spanggard, Iben, Højgaard, Martin, Belcaid, Laila, Yde, Christina, Lassen, Ulrik, Noeroexe, Dorte

Get full text

CTIM-23. EVIDENCE OF T CELL ACTIVATION AND INTRATUMORAL NIVOLUMAB-PRESENCE IN GLIOBLASTOMA PATIENTS TREATED WITH NIVOLUMAB AND BEVACIZUMAB by Skadborg, Signe, Maarup, Simone, Draghi, Arianna, Borch, Annie, Svane, Inge Marie, Hasselbalch, Benedikte, Poulsen, Hans, Lassen, Ulrik, Hadrup, Sine

“…Glioblastoma (GBM) is an aggressive brain tumor with a dismal prognosis. Salvage neurosurgical resection is performed if possible and GBM patients are…”
Get full text

Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial by Hasselbalch, Benedikte, Lassen, Ulrik, Hansen, Steinbjørn, Holmberg, Mats, Sørensen, Morten, Kosteljanetz, Michael, Broholm, Helle, Stockhausen, Marie-Thérése, Poulsen, Hans Skovgaard

“…The aim of this clinical trial was to investigate safety and efficacy when combining cetuximab with bevacizumab and irinotecan in patients with recurrent…”
Get full text

CTIM-22. NIVOLUMAB AND BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA; T-CELL REACTIVITY AGAINST AUTOLOGOUS TUMOR CELLS by Maarup, Simone, Skadborg, Signe, Borch, Annie, Draghi, Arianna, Hasselbalch, Benedikte, Østrup, Olga, Scheie, David, Skjoeth-Rasmussen, Jane, Law, Ian, Svane, Inge Marie, Poulsen, Hans, Hadrup, Sine, Lassen, Ulrik

Get full text

Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [18F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastoma by Henriksen, Otto M., Hansen, Adam E., Muhic, Aida, Marner, Lisbeth, Madsen, Karine, Møller, Søren, Hasselbalch, Benedikte, Lundemann, Michael J., Scheie, David, Skjøth-Rasmussen, Jane, Poulsen, Hans S., Larsen, Vibeke A., Larsson, Henrik B. W., Law, Ian

“…Purpose Both amino acid positron emission tomography (PET) and magnetic resonance imaging (MRI) blood volume (BV) measurements are used in suspected recurrent…”
Get full text

Implementing targeted therapies in the treatment of glioblastoma: Previous shortcomings, future promises, and a multimodal strategy recommendation by Fougner, Vincent, Hasselbalch, Benedikte, Lassen, Ulrik, Weischenfeldt, Joachim, Poulsen, Hans Skovgaard, Urup, Thomas

“…The introduction of targeted therapies to the field of oncology has prolonged the survival of several tumor types. Despite extensive research and numerous…”
Get full text

EPEN-10. SPINAL EPENDYMOMA WITH MYCN-AMPLIFICATION – A DISEASE OF CHILDHOOD AND YOUNG ADULTHOOD WITH DISMAL PROGNOSIS by Ghasemi, David R, Sill, Martin, Okonechnikov, Konstantin, Shatara, Margaret, Yip, Stephen, Reisz, Zita, Plate, Karl-Heinz, Scheie, David, Hasselbalch, Benedikte, Dohmen, Hildegard, Chaouch, Amel, Jabado, Nada, den Dunnen, Wilfred F A, Wesseling, Pieter, Fröhling, Stefan, Donson, Andrew, Capper, David, Schüller, Ulrich, Pfister, Stefan M, Reuss, David E, Pajtler, Kristian W

“…Spinal ependymoma (EPN) with MYCN-amplification (SP-EPN-MYCN) was recently recognized as a distinct tumor type within the 2021 WHO classification of CNS…”
Get full text

MRI and [18F]FET PET for early response assessment of Nivolumab and Bevacizumab in patients with recurrent high grade astrocytic glioma by Henriksen, Otto Mølby, Maarup, Simone, Hasselbalch, Benedikte, Poulsen, Hans Skovgaard, Christensen, Ib Jarle, Madsen, Karine, Larsen, Vibeke Andrée, Lassen, Ulrik, Law, Ian

Get full text

Bevacizumab plus irinotecan in the treatment patients with progressive recurrent malignant brain tumours by Poulsen, Hans Skovgaard, Grunnet, Kirsten, Sorensen, Morten, Olsen, Preben, Hasselbalch, Benedikte, Nelausen, Knud, Kosteljanetz, Michael, Lassen, Ulrik

“…We retrospectively determined the efficacy and safety of a combination of bevacizumab and irinotecan in a consecutive series of 52 heavily pre-treated patients…”
Get more information

Abstract 1046: Tracking tumor mutations in ctDNA through repetitive plasma samples in patients with newly diagnosed brain cancer by Nørøxe, Dorte Schou, Ahlborn, Lise Barlebo, Fougner, Vincent, Urup, Thomas, Hasselbalch, Benedikte, Yde, Christina Westmose, Poulsen, Hans Skovgaard, Lassen, Ulrik

“…Introduction: Glioblastoma (GBM) is an aggressive brain cancer with a median overall survival of 16-24 months. Evaluation of treatment effect can be difficult…”
Get full text

ATIM-01. NIVOLUMAB AND BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA; A TRANSLATIONAL TRIAL IN PROGRESS by Eibye, Simone, Hasselbalch, Benedikte, Marie Svane, Inge, Reker Hadrup, Sine, Rønn Olsen, Lars, Skjoeth-Rasmussen, Jane, Scheie, David, Østrup, Olga, Skovgaard Poulsen, Hans, Lassen, Ulrik

“…Abstract Glioblastoma multiforme (GBM) is an aggressive brain tumor with a poor prognosis. Standard of care at diagnosis is surgical resection, followed by…”
Get full text

Added prognostic value of DCE blood volume imaging in patients with suspected recurrent or residual glioblastoma – a hybrid [18F]FET PET/MRI study by Henriksen, Otto Mølby, Muhic, Aida, Lundemann, Michael Juncker, Larsson, Henrik Bo Wiberg, Lindberg, Ulrich, Andersen, Thomas Lund, Hasselbalch, Benedikte, Møller, Søren, Marner, Lisbeth, Madsen, Karine, Larsen, Vibeke Andrée, Poulsen, Hans Skovgaard, Hansen, Adam Espe, Law, Ian

Get full text

Actionable alterations in glioblastoma: Insights from the implementation of genomic profiling as the standard of care from 2016 to 2023 by Fougner, Vincent, Urup, Thomas, Poulsen, Hans Skovgaard, Grunnet, Kirsten, Westmose, Christina Yde, Melchior, Linea Cecilie, Larsen, Karen Bonde, Højgaard, Martin, Spanggaard, Iben, Belcaid, Laila, Rohrberg, Kristoffer Staal, Lassen, Ulrik, Hasselbalch, Benedikte, Nørøxe, Dorte Schou

Get full text